G Moreira T, Gauthier CD, Murphy L, Lanser TB, et al. Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proc Natl Acad Sci U S A 2023;120:e2220272120.
PMID: 36881624